Officially Listed on Nasdaq, Anthropic CEO Affirms AI Safety Remains Top Priority
Anthropic CEO Dario Amodei affirmed his company’s commitment to ensuring the safety of artificial intelligence (AI) and accelerating medical breakthroughs after Anthropic officially listed its shares on Nasdaq. In a statement published on Anthropic’s official account on Thursday (19/11), Amodei emphasized that the company’s stronger financial position following its IPO has only strengthened its resolve not to yield to business or political pressure, in order to ensure that the technology remains under human control.
Amodei shared the personal story behind founding Anthropic: he and his younger sister, Daniela, lost their father to an illness for which a cure was discovered only several years later. With the help of AI models such as Claude in research into protein folding, drug design, and cancer genetics, he believes that artificial intelligence working alongside humans could compress a century of scientific and medical progress into just one decade.
At the same time, he warned that AI technology brings real risks, ranging from misuse by individuals or nations and economic disruption to the loss of control over systems. For this reason, Anthropic is committed to carefully regulating the pace of training and system launches, as well as conducting multiple layers of testing to prevent biological and cyber risks.
Through what he calls a race to the top, Amodei hopes Anthropic’s success will prove that prioritizing safety in AI development can still build a successful business. This move is expected to inspire everyone in the technology industry to adopt similar safety standards for the long-term benefit of society at large.
#NvidiaBoardReportedlySplitOverHuang’sReturn
#CanGTA6'sLaunchLiftTTWOShares?
#BTCRemainsUnderPressureAfterHawkishFOMCMinutes
$ANTHROPIC $NVDA $ETH
Anthropic CEO Dario Amodei affirmed his company’s commitment to ensuring the safety of artificial intelligence (AI) and accelerating medical breakthroughs after Anthropic officially listed its shares on Nasdaq. In a statement published on Anthropic’s official account on Thursday (19/11), Amodei emphasized that the company’s stronger financial position following its IPO has only strengthened its resolve not to yield to business or political pressure, in order to ensure that the technology remains under human control.
Amodei shared the personal story behind founding Anthropic: he and his younger sister, Daniela, lost their father to an illness for which a cure was discovered only several years later. With the help of AI models such as Claude in research into protein folding, drug design, and cancer genetics, he believes that artificial intelligence working alongside humans could compress a century of scientific and medical progress into just one decade.
At the same time, he warned that AI technology brings real risks, ranging from misuse by individuals or nations and economic disruption to the loss of control over systems. For this reason, Anthropic is committed to carefully regulating the pace of training and system launches, as well as conducting multiple layers of testing to prevent biological and cyber risks.
Through what he calls a race to the top, Amodei hopes Anthropic’s success will prove that prioritizing safety in AI development can still build a successful business. This move is expected to inspire everyone in the technology industry to adopt similar safety standards for the long-term benefit of society at large.
#NvidiaBoardReportedlySplitOverHuang’sReturn
#CanGTA6'sLaunchLiftTTWOShares?
#BTCRemainsUnderPressureAfterHawkishFOMCMinutes
$ANTHROPIC $NVDA $ETH